Moderna's Personalized Cancer Vaccine Trial Data Released, Showing Efficacy Against Melanoma
Moderna released trial results for its personalized cancer vaccine, reporting a 42% reduction in melanoma recurrence. This highly anticipated data was reportedly leaked, causing Moderna's stock to tumble despite the positive efficacy findings. The primary claim of efficacy comes directly from Moderna's trial results.
3 articles from 2 outlets covered this story. The underlying claim is sourced from a press release.
What do all outlets agree on?
2 outlets covered “Moderna's Personalized Cancer Vaccine Trial Data Released, Showing Efficacy Against…”. All of them report the following:
- Moderna released trial results for its personalized cancer vaccine
- The vaccine targets melanoma
- The trial results showed efficacy
- A data leak occurred
- Moderna's stock tumbled
Which outlets covered this?
All 3 articles found on this story, grouped by the stance of the piece. Every link goes to the original publisher.
pragmatist3